Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.
Caselli G, Bonazzi A, Lanza M, Ferrari F, Maggioni D, Ferioli C, Giambelli R, Comi E, Zerbi S, Perrella M, Letari O, Di Luccio E, Colovic M, Persiani S, Zanelli T, Mennuni L, Piepoli T, Rovati LC.
Caselli G, et al. Among authors: zanelli t.
Arthritis Res Ther. 2018 Mar 1;20(1):39. doi: 10.1186/s13075-018-1537-8.
Arthritis Res Ther. 2018.
PMID: 29490676
Free PMC article.